Our findings extend our understanding of VPS35 neurobiology, and have important implications for interpretation of mutation effects induced by exogenous protein expression and the potential utility of LRRK2 kinase inhibitors in the treatment of non-LRRK2 PD. Here, LRRK2 is linked to Parkinson disease.